SEARCH

SEARCH BY CITATION

REFERENCES

  • Beral, V., Hermon, C., Muñoz, N. and Devesa, S., Cervical cancer. Cancer Surv., 19/20, 265-283 1994).
  • Breslow, N.E., Extra-Poisson variation in log-linear models. Appl. Stat., 33, 38-44 (1984).
  • Clayton, D. and Schifflers, E., Models for temporal variation in cancer rates. II: Age-period-cohort models. Statist. Med., 6, 469-481 (1987).
  • Coleman, M.P., Estàve, J., Damiecki, P., Arslan, A. and Renard, H., Trends in cancer incidence and mortality, IARC Sci. Publ. 121, IARC, Lyon 1993).
  • Devesa, S.S., Young, J.L., Brinton, L.A. and Fraumeni, J.F. Jr., Recent trends in cervix uteri. Cancer, 64, 2184-2190 (1989).
  • Eide, T.J., Cancer of the uterine cervix in Norway by histological type 1970-74. J. nat. Cancer Inst., 79, 199-205 (1987).
  • Estàve, J., International study of time trends. Some methodological considerations. Ann. N.Y. Acad. Sci., 609, 77-84 (1990).
  • Estàve, J., Benhamou, E. and Raymond, L., Descriptive epidemiology. Statistical methods in cancer research, Vol. IV, IARC Sci. Publ. 128, IARC, Lyon 1994).
  • Fernandez, L., Lence, J.J., Cabezas, E., Romero, T. and Camacho, R., Evaluation of the cervical cancer control program in Cuba. Bull. Pan. Amer. Health Org., 30, 387-391 (1996).
  • Gibson, L., Spiegelhalter, D.J., Camilleri-Ferrante, C. and Day, N.E., Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993. J. med. Screen., 4, 44-48 (1997).
  • Hakama, M., Screening for cervical cancer: experience of the Nordic countries. In: E.Franco and J.Monsonego (eds.), New developments in cervical cancer screening and prevention, pp. 190-199, Blackwell, Oxford (1997).
  • Hakama, M., Chamberlain, J., Day, N.E., Miller, A.B. and Prorok, P.C., Evaluation of screening programmes for gynaecological cancer. Brit. J. Cancer, 52, 669-673 (1985).
  • Herrero, R., Schiffman, M.H., Hildesheim, A., Bratti, C., Rodriguez, A.C., Sherman, M.E. and Morales, J., Is cervical cancer cytological screening valuable in developing countries. In: E.Franco and J.Monsonego (eds.), New developments in cervical cancer screening and prevention, pp. 241-249, Blackwell, Oxford (1997).
  • Holford, T.R., The estimates of age, period and cohort effects for vital rates. Biometrics, 39, 311-324 (1983).
  • Lazcano-Ponce, E.C., Buiatti, E., Najera-Aguilar, P., Alonso-De-Ruiz, P. and Hernandez-Avila, M., Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control, 9, 241-251 (1998).
  • Mitchell, H., Medley, G., Gordon, I. and Giles, G., Cervical cytology reported as negative risk of adenocarcinomas of the cervix: no strong evidence of benefit. Brit. J. Cancer, 71, 894-897 (1995).
  • Muir, C., Waterhouse, J., Mack, T., Powel, J. and Whelan, S. (eds.), Cancer incidence in five continents, Vol. V, IARC Sci. Publ. 88, IARC, Lyon 1987).
  • Nieminen, P.M., Kallio, M. and Hakama, M., The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet. Gynecol., 85, 1017-1020 (1995).
  • Parkin, D.M., Muir, C.S., Whelan, S.L., Gao, Y.T., Ferlay, J. and Powell, L. (eds.), Cancer incidence in five continents, Vol. VI, IARC Sci. Publ. 120, IARC, Lyon 1992).
  • Parkin, D.M., Nguyen-Dinh, X. and Day, N.E., The impact of screening on the incidence of cervical cancer in England and Wales 1963-1978. Brit. J. Obstet. Gynaecol., 92, 150-157 (1985).
  • Parkin, D.M., Pisani, P. and Ferlay, J., Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer, 54, 827-841 (1999).
  • Parkin, D.M., Whelan, S.L., Ferlay, J., Raymond, L. and Young, J. (eds.), Cancer incidence in five continents, Vol. VII, IARC Sci. Publ. 143, IARC, Lyon 1997).
  • Patnick, J., Has screening for cervical cancer been successful? Brit. J. Obstet. Gynaecol., 104, 876-878 (1997).
  • Percy, C., Van Holten, V. and Muir, C. (eds.), International classification of diseases for oncology (2nd ed.), World Health Organization, Geneva 1990).
  • Pompe kirn, V., Kovačič, J. and Primic Žakelj, P., Epidemiological evaluation of cervical cancer screening in Slovenia up to 1986. Europ. J. Gynaecol. Oncol., 13, 75-82 (1992).
  • Quinn, M., Babb, P., Jones, J. and Allen, E., Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Brit. med. J., 3, 904-908 (1999).
  • Sigurdsson, K., Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993. Europ. J. Cancer, 31, 728-734 (1995).
  • Sigurdsson, K., The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995. Acta Obstet. Gynecol. Scand., 78, 478-485 (1999).
  • Vizcaino, A.P., Moreno, V., Bosch, F.X., Muñoz, N., Barros-Dios, X. and Parkin, M., International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int. J. Cancer, 75, 536-545 (1998).
  • Vlasàk, V., Plesko, I., Dimitrova, E. and Hudáková, G., Recent trends in uterine cervix cancer in Slovakia. Neoplasma, 3, 533-539 (1991).
  • Wabinga, H.R., Parkin, D.M., Wabwire-Mangen, F. and Nambooze, S., Temporal variation in the incidence of cancer in an African population of Kyadondo County, Uganda, 1960-1997. Brit. J. Cancer, (1999). (In press).
  • Walker, J.J., Brewster, D., Gould, A. and Raab, G.M., Trends in incidence and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994). Publ. Health, 112, 373-378 (1998).
  • Waterhouse, J., Muir, C., Shanmugaratnam, K. and Powell, J. (eds.), Cancer incidence in five continents, Vol. IV, IARC Sci. Publ. 42, IARC, Lyon 1982).